Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Other Non-Current Liabilities (2016 - 2026)

Champions Oncology has reported Other Non-Current Liabilities over the past 16 years, most recently at $27000.0 for Q1 2026.

  • Quarterly results put Other Non-Current Liabilities at $27000.0 for Q1 2026, down 90.53% from a year ago — trailing twelve months through Jan 2026 was $27000.0 (down 90.53% YoY), and the annual figure for FY2025 was $85000.0, down 78.8%.
  • Other Non-Current Liabilities for Q1 2026 was $27000.0 at Champions Oncology, down from $46000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for CSBR hit a ceiling of $660000.0 in Q3 2022 and a floor of $27000.0 in Q1 2026.
  • Median Other Non-Current Liabilities over the past 5 years was $391000.0 (2022), compared with a mean of $357117.6.
  • Biggest five-year swings in Other Non-Current Liabilities: skyrocketed 172.73% in 2022 and later crashed 90.53% in 2026.
  • Champions Oncology's Other Non-Current Liabilities stood at $624000.0 in 2022, then dropped by 23.72% to $476000.0 in 2023, then tumbled by 31.93% to $324000.0 in 2024, then tumbled by 85.8% to $46000.0 in 2025, then plummeted by 41.3% to $27000.0 in 2026.
  • The last three reported values for Other Non-Current Liabilities were $27000.0 (Q1 2026), $46000.0 (Q4 2025), and $66000.0 (Q3 2025) per Business Quant data.